Barry J Aldous from 351 D St, Redwood City, CA 94063

Barry Aldous Phones & Addresses

351 D St, Redwood City, CA 94063
San Carlos, CA
San Jose, CA

Work

Company:

Antiva biosciences
Mar 2018
Position:

Associate director product development

Education

Degree:

Bachelors, Bachelor of Science
School / High School:

The University of Huddersfield
Specialities:

Chemistry

Skills

Pharmaceutical Industry • Drug Development • Inhalation • Materials Science • Technology Transfer • Formulation • Gmp • Drug Delivery • Analytical Chemistry • Glp • Pharmaceutics • Biotechnology • Drug Discovery • Hplc • Chemistry • Biopharmaceuticals • R&D • Validation • Pharmaceutical Research • Change Control • Clinical Development • Lc Ms • Ind • Dissolution • Quality By Design • Fda • Chromatography • Regulatory Affairs • Organic Chemistry • Medicinal Chemistry • Cro • Clinical Trials • Lims • Uv/Vis • Regulatory Submissions • Sop • Pharmacology • V&V • Organic Synthesis • Lifesciences • Pharmacokinetics • Statistical Data Analysis

Industries

Pharmaceuticals

Resumes

Associate Director Product Development

view source

Location:

South San Francisco, CA

Industry:

Pharmaceuticals

Work:

Antiva Biosciences
Associate Director Product Development
Barry Aldous Consulting Jan 2018 - Mar 2018
Independent Consultant
Novartis Jul 2015 - Dec 2017
Fellow, Phad Project Lead and Project Manager
Pfizer Aug 2009 - Jul 2015
Senior Principal Scientist
Pfizer Mar 2006 - Jul 2009
Principal Scientist

Education:

The University of Huddersfield
Bachelors, Bachelor of Science, Chemistry

Skills:

Pharmaceutical Industry
Drug Development
Inhalation
Materials Science
Technology Transfer
Formulation
Gmp
Drug Delivery
Analytical Chemistry
Glp
Pharmaceutics
Biotechnology
Drug Discovery
Hplc
Chemistry
Biopharmaceuticals
R&D
Validation
Pharmaceutical Research
Change Control
Clinical Development
Lc Ms
Ind
Dissolution
Quality By Design
Fda
Chromatography
Regulatory Affairs
Organic Chemistry
Medicinal Chemistry
Cro
Clinical Trials
Lims
Uv/Vis
Regulatory Submissions
Sop
Pharmacology
V&V
Organic Synthesis
Lifesciences
Pharmacokinetics
Statistical Data Analysis

Us Patents

Stable Compositions
view source
US Patent:

6503411, Jan 7, 2003
Filed:

May 22, 2000
Appl. No.:

09/576167
Inventors:

Felix Franks - London, GB
Barry John Aldous - Mountain View CA
Anthony Auffret - Kent, GB
Assignee:

Inhale Therapeutic Systems, Inc. - San Carlos CA
International Classification:

C09K 3102
US Classification:

252 1, 25218229, 124 29, 124 42, 124 58, 124 60
Abstract:

In a composition which has an amorphous, undercooled, glassy phase containing a water-soluble or water-swellable substance in an amorphous form, a sugar, which is capable of existing as a crystalline hydrate, is used as an agent to dehydrate the amorphous phase by crystallisation therefrom, and thereby enhance the glass transition temperature of the residual amorphous phase.

Barry J Aldous